Related Experiment Video
Updated: Aug 17, 2026

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Published on: September 19, 2018
Tyrosine kinase - Role and significance in Cancer
Manash K Paul1, Anup K Mukhopadhyay
1Department of Biotechnology, National Institute of Pharmaceutical Education and Research, Sector-67, S.A.S Nagar, Mohali, Punjab, India-160062.
Abstract:
Tyrosine kinases are important mediators of the signaling cascade, determining key roles in diverse biological processes like growth, differentiation, metabolism and apoptosis in response to external and internal stimuli. Recent advances have implicated the role of tyrosine kinases in the pathophysiology of cancer. Though their activity is tightly regulated in normal cells, they may acquire transforming functions due to mutation(s), overexpression and autocrine paracrine stimulation, leading to malignancy. Constitutive oncogenic activation in cancer cells can be blocked by selective tyrosine kinase inhibitors and thus considered as a promising approach for innovative genome based therapeutics. The modes of oncogenic activation and the different approaches for tyrosine kinase inhibition, like small molecule inhibitors, monoclonal antibodies, heat shock proteins, immunoconjugates, antisense and peptide drugs are reviewed in light of the important molecules. As angiogenesis is a major event in cancer growth and proliferation, tyrosine kinase inhibitors as a target for anti-angiogenesis can be aptly applied as a new mode of cancer therapy. The review concludes with a discussion on the application of modern techniques and knowledge of the kinome as means to gear up the tyrosine kinase drug discovery process.
Insights
Tyrosine kinases play crucial roles in cell signaling and cancer development. Targeting these kinases with inhibitors offers a promising therapeutic strategy for various cancers, including those involving angiogenesis.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Tyrosine kinases are key signaling mediators in cellular processes.
- Aberrant tyrosine kinase activity is implicated in cancer pathophysiology.
- Targeting tyrosine kinases is a promising strategy for cancer therapy.
Purpose of the Study:
- To review the modes of oncogenic activation of tyrosine kinases.
- To discuss various approaches for tyrosine kinase inhibition.
- To explore the role of tyrosine kinase inhibitors in anti-angiogenesis therapy.
Main Methods:
- Literature review of tyrosine kinase activation and inhibition.
- Analysis of different drug modalities targeting tyrosine kinases.
- Discussion of kinome knowledge for drug discovery.
Main Results:
- Tyrosine kinases can acquire oncogenic functions through mutations or overexpression.
- Various inhibitors, including small molecules and antibodies, are available.
- Tyrosine kinase inhibitors show potential in anti-angiogenesis cancer therapy.
Conclusions:
- Selective tyrosine kinase inhibitors represent a significant therapeutic advance.
- Targeting angiogenesis via tyrosine kinases offers a novel cancer treatment approach.
- Leveraging kinome knowledge can accelerate tyrosine kinase drug discovery.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Receptor Tyrosine Kinases
Mitogens and the Cell Cycle
PI3K/mTOR/AKT Signaling Pathway
MAPK Signaling Cascades
